<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30043915</article-id><article-id pub-id-type="pmc">6089132</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2017-0164</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Are Pre and Postoperative Platelet to Lymphocyte Ratio and Neutrophil
to Lymphocyte Ratio Associated with Early Postoperative AKI Following
CABG?</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Parlar</surname><given-names>Hakan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/><role>MD</role></contrib><contrib contrib-type="author"><name><surname>&#x0015e;a&#x0015f;k&#x00131;n</surname><given-names>H&#x000fc;seyin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><aff id="aff1">
<label>1</label>Department of Cardiovascular Surgery, Derince Training and
Research Hospital, Kocaeli, Turkey.</aff></contrib-group><author-notes><corresp id="c1">Correspondence Address: Hakan Parlar, SBU Derince Training and
Research Hospital, Department of Cardiovascular Surgery - Kocaeli, Turkey - Zip
code: 41900. E-mail: <email>hakanparlarcvs@gmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>May-Jun</season><year>2018</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>May-Jun</season><year>2018</year></pub-date><volume>33</volume><issue>3</issue><fpage>233</fpage><lpage>241</lpage><history><date date-type="received"><day>06</day><month>8</month><year>2017</year></date><date date-type="accepted"><day>11</day><month>3</month><year>2018</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p>In this study, we investigated the role of two of the recent biomarkers of
inflammation on the development of acute kidney injury in the early
postoperative period of isolated coronary artery bypass grafting.</p></sec><sec><title>Methods</title><p>Three hundred and eleven patients, who underwent isolated coronary artery
bypass grafting with cardiopulmonary bypass by the same surgery team in our
clinic between May 2010 and October 2014, who had a preoperative serum
creatinine level lower than 1.5 mg/dl were included in the study. These
patients' records were reviewed retrospectively. The diagnosis of acute
kidney injury was performed according to the Kidney Disease Improving Global
Outcomes 2012 Acute Kidney Injury Guideline criteria. Patients who developed
acute kidney injury in the early postoperative period were classified as
Group-1 (n=62) and the patients with normal postoperative renal functions
were classified as Group-2 (n=249). The demographic data, body mass index,
comorbidities, hematologic/biochemical profiles, preoperative ejection
fraction, blood transfusion history, and operative data of the groups were
compared. Univariate analyses were performed to determine significant
clinical factors, and multiple logistic regression analyses were
subsequently done to determine independent predictors of acute kidney
injury.</p></sec><sec><title>Results</title><p>Sixty-two (19.9%) patients developed acute kidney injury during the first 72
hours postoperatively. Multivariate logistic regression analyses revealed
preoperative increased creatinine (<italic>P</italic>=0.0001), C-reactive
protein (<italic>P</italic>=0.02), neutrophil-lymphocyte ratio
(<italic>P</italic>=0.04) and platelet-lymphocyte ratio
(<italic>P</italic>=0.002); increased postoperative first day leukocyte
count (<italic>P</italic>=0.03), C-reactive protein levels
(<italic>P</italic>=0.02), neutrophil-lymphocyte ratio
(<italic>P</italic>=0.002), platelet-lymphocyte ratio
(<italic>P</italic>=0.01) and increased intubation time
(<italic>P</italic>=0.006) as independent predictors of early
postoperative acute kidney injury in patients who underwent isolated
coronary artery bypass grafting.</p></sec><sec><title>Conclusion</title><p>The preoperative and postoperative increased levels of neutrophil-lymphocyte
ratio and platelet-lymphocyte ratio which can be calculated by simple
methods from routine blood analysis showed us that these parameters are
independent biomarkers directly related to development of acute kidney
injury in the early postoperative period.</p></sec></abstract><kwd-group><kwd>Coronary Artery Bypass</kwd><kwd>Acute Kidney Injury</kwd><kwd>Biomarkers</kwd><kwd>Inflammation</kwd></kwd-group></article-meta></front><body><table-wrap id="t6" orientation="portrait" position="float"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="42%" span="1"/><col width="5%" span="1"/><col width="5%" span="1"/><col width="42%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th align="center" colspan="2" style="background-color:#e6e7e8" rowspan="1">&#x000a0;</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ACT</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Activated clotting
time</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">LIMA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Left internal mammary
artery</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">AKI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Acute kidney injury</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">LVEF</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Left ventricular
ejection fraction</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">AUC</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Area under curve</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">NLR</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Neutrophil to lymphocyte
ratio</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CABG</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Coronary artery bypass
grafting</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PCI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Percutanous coronary
intervention</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CRP</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= C-reactive protein</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PLR</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Platelet to lymphocyte
ratio</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CPB</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Cardiopulmonary
bypass</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ROC</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Receiver operating
curve</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ECG</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Electrocardiography</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">RRT</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Renal replacement
therapy</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">KDIGO</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Kidney Disease Improving
Global Outcomes</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">STEMI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= ST-elevated myocardial
infarction</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">LAD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Left anterior descending
artery</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">WBC</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= White blood cell</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Acute kidney injury (AKI) is one of the frequent pathological conditions following
cardiac surgery which causes prolonged hospital and intensive care unit stay, higher
health costs and mortality<sup>[</sup><sup><xref rid="r1" ref-type="bibr">1</xref></sup><sup>]</sup>. The incidence of AKI after cardiac surgery was
reported as 5-30% and 1-2% of these patients required renal replacement therapy
(RRT)<sup>[</sup><sup><xref rid="r2" ref-type="bibr">2</xref></sup><sup>]</sup>.
AKI is a complicated pathology in a broad clinic spectrum from minimally increased
serum creatinine levels to anuric status<sup>[</sup><sup><xref rid="r3" ref-type="bibr">3</xref></sup><sup>]</sup>. Multiple factors have been implicated
as contributors to postoperative AKI including advanced age, female gender, chronic
kidney disease, time delay between heart catheterization and surgery, aortic cross
clamping time, duration of cardiopulmonary bypass (CPB) time, differences in the
preoperative and intraoperative mean arterial pressures and blood transfusion
following surgery<sup>[</sup><sup><xref rid="r3" ref-type="bibr">3</xref></sup><sup>-</sup><sup><xref rid="r5" ref-type="bibr">5</xref></sup><sup>]</sup>.</p><p>Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) are
recently described clinical parameters which can be found by detailed analysis of
hemogram. There are many disorders with severe prognosis including peripheral
vascular diseases, coronary artery disease, some of the malignancies of
hepatobiliary and gynecological systems which are associated with elevated PLR
levels. Elevated NLR levels have been demonstrated in systemic inflammation,
cardiovascular disorders and gastrointestinal cancers<sup>[</sup><sup><xref rid="r6" ref-type="bibr">6</xref></sup><sup>-</sup><sup><xref rid="r8" ref-type="bibr">8</xref></sup><sup>]</sup>.</p><p>There have been no reports that focused on the association between the biomarkers NLR
and PLR and AKI following coronary artery bypass grafting (CABG) in the recent
literature. The aim of this study is to indicate the relationship between values of
NLR and PLR and the development of AKI in patients in the early postoperative period
of isolated CABG.</p></sec><sec sec-type="methods"><title>METHODS</title><p>The medical records of a total of 506 patients who underwent isolated CABG between
May 2010 and October 2014 were reviewed retrospectively. The operations were
performed at the same center by the same surgery team; 311 patients who had serum
creatinine levels of &#x0003c; 1.5 mg/dl who underwent isolated CABG with CPB were
included in the study. The diagnosis of AKI was made by comparison of the baseline
and postoperative serum creatinine levels to determine the presence of a predefined
significant change based on the Kidney Disease Improving Global Outcomes (KDIGO)
definition (increase in serum creatinine by &#x02265; 0.3 mg/dl within 48 hours of
surgery or increase in serum creatinine to &#x02265; 1.5 times of baseline within 3
days of cardiac surgery)<sup>[</sup><sup><xref rid="r9" ref-type="bibr">9</xref></sup><sup>]</sup>.</p><p>The diagnosis of AKI was based on the highest serum creatinine concentration measured
during the first 3 days after surgery compared with the baseline serum creatinine
concentration, defined as the last concentration measured before surgery. Urine
output was not used to define AKI, because it might be altered by diuretics
administered during anaesthesia and CPB. Patients who developed AKI in the early
postoperative period were classified as Group-1 (n=62) and the patients with normal
postoperative renal functions were classified as Group-2 (n=249).</p><p>AKI was also staged for severity according to the following KDIGO criteria:</p><p>
<list list-type="bullet"><list-item><p>Stage 1 - increase in serum creatinine by &#x02265; 0.3 mg/dl or 1.5 to
1.9 times of baseline,</p></list-item><list-item><p>Stage 2 - increase in serum creatinine 2.0 to 2.9 times of baseline,</p></list-item><list-item><p>Stage 3 - increase in serum creatinine 3.0 or more times of baseline or
an increase in serum creatinine by &#x02265; 4.0 mg/dl or initiation of
RRT<sup>[</sup><sup><xref rid="r10" ref-type="bibr">10</xref></sup><sup>]</sup>.</p></list-item></list>
</p><p>We excluded the patients previously diagnosed with end-stage renal disease who were
on dialysis. The patients who had peripheral arterial disease, valvular heart
disease, decompensated congestive heart failure, congenital cardiac disease, left
ventricular systolic function disorder (left ventricular ejection fraction &#x02264;
30%), cerebrovascular disease in the last 30 days, renal impairment (serum
creatinine &#x0003e; 1.5 mg/dl), chronic obstructive pulmonary disease, malignancy,
endocrinologic disorders (hypothyroidism, hyperthyroidism), systemic inflammatory
diseases, hematological proliferative diseases, low hemoglobin levels (&#x02264; 10
g/dl); patients with acute infections, emergency operations, patients who were
reoperated due to hemodynamic instability or bleeding, patients who required
intra-aortic balloon pump, patients who had an acute myocardial infarction and
percutaneous coronary intervention in the last 30 days prior to operation, patients
with a diagnosis of active or chronic autoimmune diseases, patients who had steroid
treatment or chemotherapy, patients who were operated on beating heart or redo CABG
were also excluded from the study. Additionally, patients for whom data such as
serum creatinine levels or urine output were missing, were excluded.</p><p>The demographic and clinical data of the patients were obtained by using the software
system of the hospital for records and archives to investigate the patient files,
epicrisis, operation notes and laboratory results. Age, gender, smoking history,
diabetes, hypertension, hyperlipidemia, left ventricular ejection fraction (LVEF),
preoperative and postoperative laboratory parameters (hemoglobin levels; leukocyte,
platelet, lymphocyte and neutrophil counts; fasting blood glucose levels; serum
creatinine and urea), operation information, the number of grafts used, duration of
CPB and aortic cross clamping, amount of blood products used and length of stay in
the intensive care unit and hospital were recorded.</p><p>Hypertension was accepted as a blood pressure of &#x02265; 140/90 mmHg or the use of
antihypertensive drugs; smoking was accepted positive if the patient had not quitted
smoking for the last one year. Diabetes was accepted as fasting blood glucose
&#x02265; 126 mg/dl or the use of antidiabetic drugs, hyperlipidemia was accepted as
total cholesterol &#x0003e; 220 mg/dl and LDL-cholesterol &#x0003e; 130 mg/dl or the use of
antihyperlipidemic drugs.</p><p>Approximately 5 to 7 ml of venous blood samples were placed into a sterile tube with
EDTA. Hematologic parameters were calculated by an automated blood count device
(Abbott CELL-DYN 3700; Abbott Laboratory, Abbott Park, Illinois, USA) following a
waiting time of one hour. PLR was calculated by dividing the number of platelets to
the number of lymphocytes. NLR was calculated by dividing the number of neutrophils
to the number of lymphocytes.</p><p>All patients were transferred to intensive care unit intubated postoperatively. They
were extubated following onset of spontaneous breathing and normalization of
orientation and cooperation if the hemodynamic and respiratory functions were
appropriate. If there was no contraindication, 50 mg/day of metoprolol was started
orally to all patients following the first postoperative day. The diagnosis of
postoperative atrial fibrillation was made by standard 12 derivation
electrocardiography (ECG).</p><p>Written informed consent form was obtained from all the patients included in the
study. This study complied with the Declaration of Helsinki and was carried out
following approval of Ethics Committee for Clinical Trials of Medical Faculty of
Kocaeli University.</p><sec><title>Operative Technique</title><p>All patients were operated with median sternotomy under general anaesthesia and
CPB with aortic and venous cannulations following systemic heparin
administration (300 IU/kg). Activated clotting time (ACT) was maintained over
450 seconds during the operations. Standard CPB circuit and surgical management
were used. Antegrade hypothermic and hyperkalemic blood cardioplegia was applied
to all patients. Surgery was performed under moderate systemic hypothermia
(28-30&#x000ba;C). Cardiopulmonary bypass flow was maintained 2.2-2.5
l/min/m<sup>2</sup>, mean perfusion pressure was maintained between 50 and
80 mmHg, hematocrit level was maintained between 20 to 25 percent during CPB.
For the coronary bypass operations, the left internal mammary artery (LIMA) was
preferred for the arterial graft for left anterior descending artery (LAD)
revascularization, whereas saphenous venous grafts were used for the other
vessels. Distal anastomoses were done during aortic cross clamping period and
proximal anastomoses were done on beating heart onto the ascending aorta using
lateral clamp.</p></sec><sec><title>Statistical Analysis</title><p>Statistical analysis was performed using the SPSS software version 13.0 (SPSS
Inc, Chicago, IL, USA). Among the data measured, those showing normal
distribution were expressed as mean &#x000b1; standard deviation, those not
showing normal distribution were expressed as median (minimum-maximum). The data
obtained by counting were given as percentages (%). Among the data measured, the
normality of distribution was evaluated by histogram or Kolmogorov-Smirnov test,
the homogenity of distribution was evaluated by Levene's test for equality of
variance. Among the data measured, the difference between the groups was
evaluated by Student's t-test in normal and homogenous distribution and by
Mann-Whitney U test in distribution which is not normal and homogeneous. Among
the data obtained by counting, the differences between the groups were evaluated
by parametric or non-parametric Pearson Chi-Square test or Fisher's Exact test
according to the distribution being parametric or not. The effects of the risk
factors suggested to be influential on the early period AKI were studies through
the univariate logistic regression analysis. The multiple effects of the risk
factors which are influential or which are suggested to be influential in
predicting the early period AKI as a result of the univariate statistical
analysis were studied through the retrospective selective multivariate logistic
regression analysis. The odds ratio, the 95% confidence interval and the
significant level for each of the risk factors, was found. The sensitivity and
the specificity of PLR and NLR in predicting the early period AKI via receiver
operating curve (ROC) were computed and results were found as statistically
significant for <italic>P</italic>&#x0003c;0.05.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>The demographic characteristics and clinical data of the patients were summarized in
<xref rid="t1" ref-type="table">Table 1</xref>. There were no differences
between the two groups in terms of demographic or clinical data.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Comparison of patient's characteristics between the 2 groups.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Patient's Characteristics</th><th align="center" rowspan="1" colspan="1">Group I<break/>AKI (n=62)</th><th align="center" rowspan="1" colspan="1">Group II<break/>Non-AKI (n=249)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic> value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years) (median; min-max)</td><td align="center" rowspan="1" colspan="1">62 (35-83)</td><td align="center" rowspan="1" colspan="1">60 (33-82)</td><td align="center" rowspan="1" colspan="1">0.14<xref ref-type="table-fn" rid="TFN2">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Male (%)</td><td align="center" rowspan="1" colspan="1">46 (74.2%)</td><td align="center" rowspan="1" colspan="1">189 (75.9%)</td><td align="center" rowspan="2" colspan="1">0.78<xref ref-type="table-fn" rid="TFN1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Female (%)</td><td align="center" rowspan="1" colspan="1">16 (25.8%)</td><td align="center" rowspan="1" colspan="1">60 (24.1%)</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>) (median; min-max)</td><td align="center" rowspan="1" colspan="1">28.5 (19.6-37.4)</td><td align="center" rowspan="1" colspan="1">27.3 (19.0-39.4)</td><td align="center" rowspan="1" colspan="1">0.11<xref ref-type="table-fn" rid="TFN2">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension (%)</td><td align="center" rowspan="1" colspan="1">41 (66.1%)</td><td align="center" rowspan="1" colspan="1">152 (61.0%)</td><td align="center" rowspan="1" colspan="1">0.46<xref ref-type="table-fn" rid="TFN1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes mellitus (%)</td><td align="center" rowspan="1" colspan="1">29 (46.8%)</td><td align="center" rowspan="1" colspan="1">85 (34.1%)</td><td align="center" rowspan="1" colspan="1">0.07<xref ref-type="table-fn" rid="TFN1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Smoking (%)</td><td align="center" rowspan="1" colspan="1">29 (46.8%)</td><td align="center" rowspan="1" colspan="1">93 (37.3%)</td><td align="center" rowspan="1" colspan="1">0.17<xref ref-type="table-fn" rid="TFN1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Hyperlipidaemia (%)</td><td align="center" rowspan="1" colspan="1">26 (41.9%)</td><td align="center" rowspan="1" colspan="1">116 (46.6%)</td><td align="center" rowspan="1" colspan="1">0.51<xref ref-type="table-fn" rid="TFN1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Ejection fraction (%)<break/>(median; min-max)</td><td align="center" rowspan="1" colspan="1">56.5 (30-68)</td><td align="center" rowspan="1" colspan="1">58 (30-67)</td><td align="center" rowspan="1" colspan="1">0.35<xref ref-type="table-fn" rid="TFN2">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">History of atrial fibrillation (%)</td><td align="center" rowspan="1" colspan="1">7 (11.3%)</td><td align="center" rowspan="1" colspan="1">25 (10.0%)</td><td align="center" rowspan="1" colspan="1">0.77<xref ref-type="table-fn" rid="TFN1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">History of CVA (%)</td><td align="center" rowspan="1" colspan="1">2 (3.2%)</td><td align="center" rowspan="1" colspan="1">6 (2.4%)</td><td align="center" rowspan="1" colspan="1">0.66<xref ref-type="table-fn" rid="TFN1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">History of MI (%)</td><td align="center" rowspan="1" colspan="1">14 (22.6%)</td><td align="center" rowspan="1" colspan="1">51 (20.5%)</td><td align="center" rowspan="1" colspan="1">0.72<xref ref-type="table-fn" rid="TFN1">*</xref></td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>*</label><p>Pearson Chi-Square test or Fisher's Exact test</p></fn><fn id="TFN2"><label>**</label><p>Mann-Whitney U test</p></fn><fn id="TFN3"><p>BMI=body mass index; CVA=cerebrovascular accident; MI=myocardial
infarction</p></fn></table-wrap-foot></table-wrap><p>According to the KDIGO classification, 51.6% (n=32) of the patients were Stage-I,
38.7% (n=24) were Stage-II and 9.7% (n=6) were Stage-III. The preoperative blood
analysis and hematological parameters of the patients were summarized in <xref rid="t2" ref-type="table">Table 2</xref>. Preoperative creatinine levels
(<italic>P</italic>=0.0001), urea levels (<italic>P</italic>=0.0001), lymphocyte
counts (<italic>P</italic>=0.04), neutrophil counts (<italic>P</italic>=0.03), PLR
(<italic>P</italic>=0.0001), NLR (<italic>P</italic>=0.0001) and C-reactive
protein (CRP) levels(<italic>P</italic>=0.0001) were significantly different between
the groups.</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Preoperative blood results and hematological parameters of patients.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="30%" span="1"/><col width="30%" span="1"/><col width="30%" span="1"/><col width="10%" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Preoperative blood results <break/>and
hematological parameters</th><th align="center" rowspan="1" colspan="1">Group I<break/>AKI (n=62)</th><th align="center" rowspan="1" colspan="1">Group II<break/>Non-AKI (n=249)</th><th align="center" rowspan="2" colspan="1"><italic>P</italic> value</th></tr><tr><th align="center" rowspan="1" colspan="1">Median <break/>(minimum-maximum)</th><th align="center" rowspan="1" colspan="1">Median <break/> (minimum-maximum)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Preoperative hemoglobin (mg/dl)</td><td align="center" rowspan="1" colspan="1">13.9 (10.6-16.0)</td><td align="center" rowspan="1" colspan="1">13.5 (10.4-16.5)</td><td align="center" rowspan="1" colspan="1">0.24<xref ref-type="table-fn" rid="TFN4">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative hematocrit (%)</td><td align="center" rowspan="1" colspan="1">41.8 (30.6-48.9)</td><td align="center" rowspan="1" colspan="1">40.5 (30.5-48.9)</td><td align="center" rowspan="1" colspan="1">0.42<xref ref-type="table-fn" rid="TFN4">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative creatinine (mg/dl)</td><td align="center" rowspan="1" colspan="1">1.20 (0.60-1.46)</td><td align="center" rowspan="1" colspan="1">0.81 (0.60-1.47)</td><td align="center" rowspan="1" colspan="1">0.0001<xref ref-type="table-fn" rid="TFN4">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative urea (mg/dl)</td><td align="center" rowspan="1" colspan="1">23 (12-47)</td><td align="center" rowspan="1" colspan="1">18 (10-39)</td><td align="center" rowspan="1" colspan="1">0.0001<xref ref-type="table-fn" rid="TFN4">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative leukocyte count
(x10<sup>3</sup>/&#x000b5;L)</td><td align="center" rowspan="1" colspan="1">8.4 (5.2-11.4)</td><td align="center" rowspan="1" colspan="1">8.0 (3.4-11.8)</td><td align="center" rowspan="1" colspan="1">0.52<xref ref-type="table-fn" rid="TFN4">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative platelet count
(x10<sup>3</sup>/&#x000b5;L)</td><td align="center" rowspan="1" colspan="1">290 (156-444)</td><td align="center" rowspan="1" colspan="1">278 (145-445)</td><td align="center" rowspan="1" colspan="1">0.13<xref ref-type="table-fn" rid="TFN4">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative CRP (mg/L)</td><td align="center" rowspan="1" colspan="1">1.12 (0.36-4.58)</td><td align="center" rowspan="1" colspan="1">0.49 (0.16-4.71)</td><td align="center" rowspan="1" colspan="1">0.0001<xref ref-type="table-fn" rid="TFN4">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative lymphocyte count
(x10<sup>3</sup>/&#x000b5;L)</td><td align="center" rowspan="1" colspan="1">1.8 (1.0-4.9)</td><td align="center" rowspan="1" colspan="1">2.2 (0.9-4.9)</td><td align="center" rowspan="1" colspan="1">0.04<xref ref-type="table-fn" rid="TFN4">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative neutrophil count
(x10<sup>3</sup>/&#x000b5;L)</td><td align="center" rowspan="1" colspan="1">5.9 (2.8-9.6)</td><td align="center" rowspan="1" colspan="1">5.0 (1.4-9.7)</td><td align="center" rowspan="1" colspan="1">0.003<xref ref-type="table-fn" rid="TFN4">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative NLR</td><td align="center" rowspan="1" colspan="1">3.3 (1.2-8.9)</td><td align="center" rowspan="1" colspan="1">2.3 (0.6-8.0)</td><td align="center" rowspan="1" colspan="1">0.0001<xref ref-type="table-fn" rid="TFN4">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative PLR</td><td align="center" rowspan="1" colspan="1">154.5 (84.7-191.7)</td><td align="center" rowspan="1" colspan="1">122.9 (80.0-199.3)</td><td align="center" rowspan="1" colspan="1">0.0001<xref ref-type="table-fn" rid="TFN4">*</xref></td></tr></tbody></table><table-wrap-foot><fn id="TFN4"><label>*</label><p>Mann-Whitney U test</p></fn><fn id="TFN5"><p>CRP=C-reactive protein; NLR=neutrophil to lymphocyte ratio; PLR=platelet
to lymphocyte ratio</p></fn></table-wrap-foot></table-wrap><p>The early postoperative blood analysis and hematological parameters of the patients
were summarized in <xref rid="t3" ref-type="table">Table 3</xref>. Leukocyte counts
(<italic>P</italic>=0.0001) in the first and third postoperative days; CRP
levels (<italic>P</italic>=0.0001), lymphocyte counts (<italic>P</italic>=0.0001),
neutrophil counts (respectively <italic>P</italic>=0.009, <italic>P</italic>=0.03,
<italic>P</italic>=0.0001), NLR (<italic>P</italic>=0.0001) and PLR
(<italic>P</italic>=0.0001) in the first, third and seventh postoperative days
were significantly different between the groups.</p><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Early postoperative blood results and hematological parameters of
patients.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="40%" span="1"/><col width="15%" span="1"/><col width="15%" span="1"/><col width="15%" span="1"/><col width="15%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="2">Early postoperative period
blood results <break/>and hematological parameters</th><th align="center" rowspan="1" colspan="1">Group I<break/>AKI (n=62)</th><th align="center" rowspan="1" colspan="1">Group II<break/>Non-AKI (n=249)</th><th align="center" rowspan="2" colspan="1"><italic>P</italic> value</th></tr><tr><th align="center" rowspan="1" colspan="1">Median <break/>(minimum-maximum)</th><th align="center" rowspan="1" colspan="1">Median <break/> (minimum-maximum)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Postoperative hemoglobin (mg/dl)</td><td align="center" rowspan="1" colspan="1">1 day</td><td align="center" rowspan="1" colspan="1">8.8 (7.5-11.4)</td><td align="center" rowspan="1" colspan="1">9.0 (7.4-12.6)</td><td align="center" rowspan="1" colspan="1">0.50<xref ref-type="table-fn" rid="TFN6">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Postoperative hematocrit (%)</td><td align="center" rowspan="1" colspan="1">1 day</td><td align="center" rowspan="1" colspan="1">28.0 (24.7-36.2)</td><td align="center" rowspan="1" colspan="1">28.5 (24.3-39.0)</td><td align="center" rowspan="1" colspan="1">0.52<xref ref-type="table-fn" rid="TFN6">*</xref></td></tr><tr><td align="left" rowspan="3" colspan="1">Postoperative leukocyte count
(x10<sup>3</sup>/&#x000b5;L)</td><td align="center" rowspan="1" colspan="1">1 day</td><td align="center" rowspan="1" colspan="1">15.1 (7.6-21.1)</td><td align="center" rowspan="1" colspan="1">12.5 (4.7-32.3)</td><td align="center" rowspan="1" colspan="1">0.0001<xref ref-type="table-fn" rid="TFN6">*</xref></td></tr><tr><td align="center" rowspan="1" colspan="1">3 days</td><td align="center" rowspan="1" colspan="1">13.3 (6.8-26.4)</td><td align="center" rowspan="1" colspan="1">11.1 (4.6-21.1)</td><td align="center" rowspan="1" colspan="1">0.0001<xref ref-type="table-fn" rid="TFN6">*</xref></td></tr><tr><td align="center" rowspan="1" colspan="1">7 days</td><td align="center" rowspan="1" colspan="1">10.3 (7.0-23.3)</td><td align="center" rowspan="1" colspan="1">9.8 (4.3-22.1)</td><td align="center" rowspan="1" colspan="1">0.30<xref ref-type="table-fn" rid="TFN6">*</xref></td></tr><tr><td align="left" rowspan="3" colspan="1">Postoperative platelet count
(x10<sup>3</sup>/&#x000b5;L)</td><td align="center" rowspan="1" colspan="1">1 day</td><td align="center" rowspan="1" colspan="1">162 (77-331)</td><td align="center" rowspan="1" colspan="1">177 (71-350)</td><td align="center" rowspan="1" colspan="1">0.17<xref ref-type="table-fn" rid="TFN6">*</xref></td></tr><tr><td align="center" rowspan="1" colspan="1">3 days</td><td align="center" rowspan="1" colspan="1">165 (65-320)</td><td align="center" rowspan="1" colspan="1">167 (70-327)</td><td align="center" rowspan="1" colspan="1">0.50<xref ref-type="table-fn" rid="TFN6">*</xref></td></tr><tr><td align="center" rowspan="1" colspan="1">7 days</td><td align="center" rowspan="1" colspan="1">214 (99-463)</td><td align="center" rowspan="1" colspan="1">231 (100-408)</td><td align="center" rowspan="1" colspan="1">0.17<xref ref-type="table-fn" rid="TFN6">*</xref></td></tr><tr><td align="left" rowspan="3" colspan="1">Postoperative CRP (mg/L)</td><td align="center" rowspan="1" colspan="1">1 day</td><td align="center" rowspan="1" colspan="1">32.1 (15.2-44.1)</td><td align="center" rowspan="1" colspan="1">26.7 (15.2-39.4)</td><td align="center" rowspan="1" colspan="1">0.0001<xref ref-type="table-fn" rid="TFN6">*</xref></td></tr><tr><td align="center" rowspan="1" colspan="1">3 days</td><td align="center" rowspan="1" colspan="1">43.9 (36.5-63.3)</td><td align="center" rowspan="1" colspan="1">41.0 (30.5-48.9)</td><td align="center" rowspan="1" colspan="1">0.0001<xref ref-type="table-fn" rid="TFN6">*</xref></td></tr><tr><td align="center" rowspan="1" colspan="1">7 days</td><td align="center" rowspan="1" colspan="1">9.5 (7.4-19.9)</td><td align="center" rowspan="1" colspan="1">8.9 (4.8-12.6)</td><td align="center" rowspan="1" colspan="1">0.0001<xref ref-type="table-fn" rid="TFN6">*</xref></td></tr><tr><td align="left" rowspan="3" colspan="1">Postoperative lymphocyte count
(x10<sup>3</sup>/&#x000b5;L)</td><td align="center" rowspan="1" colspan="1">1 day</td><td align="center" rowspan="1" colspan="1">1.1 (0.4-2.2)</td><td align="center" rowspan="1" colspan="1">1.5 (0.6-2.6)</td><td align="center" rowspan="1" colspan="1">0.0001<xref ref-type="table-fn" rid="TFN6">*</xref></td></tr><tr><td align="center" rowspan="1" colspan="1">3 days</td><td align="center" rowspan="1" colspan="1">1.1 (0.4-2.7)</td><td align="center" rowspan="1" colspan="1">1.3 (0.6-3.3)</td><td align="center" rowspan="1" colspan="1">0.0001<xref ref-type="table-fn" rid="TFN6">*</xref></td></tr><tr><td align="center" rowspan="1" colspan="1">7 days</td><td align="center" rowspan="1" colspan="1">1.4 (0.6-3.2)</td><td align="center" rowspan="1" colspan="1">1.9 (0.9-3.7)</td><td align="center" rowspan="1" colspan="1">0.0001<xref ref-type="table-fn" rid="TFN6">*</xref></td></tr><tr><td align="left" rowspan="3" colspan="1">Postoperative neutrophil count
(x10<sup>3</sup>/&#x000b5;L)</td><td align="center" rowspan="1" colspan="1">1 day</td><td align="center" rowspan="1" colspan="1">8.1 (3.9-11.7)</td><td align="center" rowspan="1" colspan="1">7.3 (2.8-9.8)</td><td align="center" rowspan="1" colspan="1">0.009<xref ref-type="table-fn" rid="TFN6">*</xref></td></tr><tr><td align="center" rowspan="1" colspan="1">3 days</td><td align="center" rowspan="1" colspan="1">7.7 (4.0-10.8)</td><td align="center" rowspan="1" colspan="1">7.4 (3.0-10.8)</td><td align="center" rowspan="1" colspan="1">0.03<xref ref-type="table-fn" rid="TFN6">*</xref></td></tr><tr><td align="center" rowspan="1" colspan="1">7 days</td><td align="center" rowspan="1" colspan="1">8.1 (3.5-11.0)</td><td align="center" rowspan="1" colspan="1">6.5 (1.4-10.5)</td><td align="center" rowspan="1" colspan="1">0.0001<xref ref-type="table-fn" rid="TFN6">*</xref></td></tr><tr><td align="left" rowspan="3" colspan="1">Postoperative NLR</td><td align="center" rowspan="1" colspan="1">1 day</td><td align="center" rowspan="1" colspan="1">7.9 (4.5-10.2)</td><td align="center" rowspan="1" colspan="1">5.1 (2.1-9.9)</td><td align="center" rowspan="1" colspan="1">0.0001<xref ref-type="table-fn" rid="TFN6">*</xref></td></tr><tr><td align="center" rowspan="1" colspan="1">3 days</td><td align="center" rowspan="1" colspan="1">7.8 (3.5-10.7)</td><td align="center" rowspan="1" colspan="1">5.4 (1.4-10.6)</td><td align="center" rowspan="1" colspan="1">0.0001<xref ref-type="table-fn" rid="TFN6">*</xref></td></tr><tr><td align="center" rowspan="1" colspan="1">7 days</td><td align="center" rowspan="1" colspan="1">5.6 (1.6-10.6)</td><td align="center" rowspan="1" colspan="1">3.3 (0.5-8.6)</td><td align="center" rowspan="1" colspan="1">0.0001<xref ref-type="table-fn" rid="TFN6">*</xref></td></tr><tr><td align="left" rowspan="3" colspan="1">Postoperative PLR</td><td align="center" rowspan="1" colspan="1">1 day</td><td align="center" rowspan="1" colspan="1">156.6 (108.2-198.9)</td><td align="center" rowspan="1" colspan="1">124.7 (72.2-188.6)</td><td align="center" rowspan="1" colspan="1">0.0001<xref ref-type="table-fn" rid="TFN6">*</xref></td></tr><tr><td align="center" rowspan="1" colspan="1">3 days</td><td align="center" rowspan="1" colspan="1">152.6 (81.5-196.3)</td><td align="center" rowspan="1" colspan="1">120.9 (69.4-172.5)</td><td align="center" rowspan="1" colspan="1">0.0001<xref ref-type="table-fn" rid="TFN6">*</xref></td></tr><tr><td align="center" rowspan="1" colspan="1">7 days</td><td align="center" rowspan="1" colspan="1">155.7 (82.5-197.9)</td><td align="center" rowspan="1" colspan="1">120.0 (68.7-169.2)</td><td align="center" rowspan="1" colspan="1">0.0001<xref ref-type="table-fn" rid="TFN6">*</xref></td></tr></tbody></table><table-wrap-foot><fn id="TFN6"><label>*</label><p>Mann-Whitney U test</p></fn><fn id="TFN7"><p>CRP=C-reactive protein; NLR=Neutrophil to lymphocyte ratio; PLR=platelet
to lymphocyte ratio</p></fn></table-wrap-foot></table-wrap><p>The intraoperative and postoperative data of the patients were shown in <xref rid="t4" ref-type="table">Table 4</xref>. Intubation time
(<italic>P</italic>=0.0001), length of stay in the intensive care unit
(<italic>P</italic>=0.0001), use of inotropic support (<italic>P</italic>=0.02)
and total length of stay in the hospital (<italic>P</italic>=0.0001) were
significantly different between the groups. We performed LIMA anastomosis to LAD in
57 (91.9%) patients in Group-1 and in 241 (96.8%) patients in Group-2.</p><table-wrap id="t4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Intraoperative and postoperative data of the patients.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="30%" span="1"/><col width="30%" span="1"/><col width="30%" span="1"/><col width="10%" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Characteristics</th><th align="center" rowspan="1" colspan="1">Group I<break/>AKI (n=62)</th><th align="center" rowspan="1" colspan="1">Group II<break/>Non-AKI (n=249)</th><th align="center" rowspan="2" colspan="1"><italic>P</italic> value</th></tr><tr><th align="center" rowspan="1" colspan="1">Median<break/>&#x000a0;(minimum-maximum)</th><th align="center" rowspan="1" colspan="1">Median <break/> (minimum-maximum)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Aortic cross clamp time (minutes)</td><td align="center" rowspan="1" colspan="1">51 (23-84)</td><td align="center" rowspan="1" colspan="1">51 (21-76)</td><td align="center" rowspan="1" colspan="1">0.73<xref ref-type="table-fn" rid="TFN9">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Cardiopulmonary bypass time (minutes)</td><td align="center" rowspan="1" colspan="1">84.5 (47-114)</td><td align="center" rowspan="1" colspan="1">84 (42-110)</td><td align="center" rowspan="1" colspan="1">0.50<xref ref-type="table-fn" rid="TFN9">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Number of distal anastomoses</td><td align="center" rowspan="1" colspan="1">3 (1-5)</td><td align="center" rowspan="1" colspan="1">3 (1-5)</td><td align="center" rowspan="1" colspan="1">0.68<xref ref-type="table-fn" rid="TFN9">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Amount of drainage (ml)</td><td align="center" rowspan="1" colspan="1">300 (200-1350)</td><td align="center" rowspan="1" colspan="1">300 (150-1250)</td><td align="center" rowspan="1" colspan="1">0.08<xref ref-type="table-fn" rid="TFN8">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Intubation time (hours)</td><td align="center" rowspan="1" colspan="1">8 (3-16)</td><td align="center" rowspan="1" colspan="1">5 (3-21)</td><td align="center" rowspan="1" colspan="1">0.0001<xref ref-type="table-fn" rid="TFN9">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Stay in the intensive care unit (hours)</td><td align="center" rowspan="1" colspan="1">37.5 (21-87)</td><td align="center" rowspan="1" colspan="1">21 (17-66)</td><td align="center" rowspan="1" colspan="1">0.0001<xref ref-type="table-fn" rid="TFN9">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Total duration of hospital stay (days)</td><td align="center" rowspan="1" colspan="1">8 (5-14)</td><td align="center" rowspan="1" colspan="1">5 (5-10)</td><td align="center" rowspan="1" colspan="1">0.0001<xref ref-type="table-fn" rid="TFN9">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Use of inotropic support (%) </td><td align="center" rowspan="1" colspan="1">16 (25.8%)</td><td align="center" rowspan="1" colspan="1">33 (13.3%)</td><td align="center" rowspan="1" colspan="1">0.02<xref ref-type="table-fn" rid="TFN8">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Use of blood products (%)</td><td align="center" rowspan="1" colspan="1">31 (50.0%)</td><td align="center" rowspan="1" colspan="1">117 (47.0%)</td><td align="center" rowspan="1" colspan="1">0.67<xref ref-type="table-fn" rid="TFN8">*</xref></td></tr></tbody></table><table-wrap-foot><fn id="TFN8"><label>*</label><p>Pearson Chi-Square test or Fisher's Exact test</p></fn><fn id="TFN9"><label>**</label><p>Mann-Whitney U test</p></fn></table-wrap-foot></table-wrap><p>The results of univariate and multivariate regression analyses of patients who
developed AKI in the early postoperative period were shown in <xref rid="t5" ref-type="table">Table 5</xref>. In the multivariate analysis of the variables which
were found statistically significant in univariate analysis associated with
postoperative AKI, increased serum creatinine (<italic>P</italic>=0.0001), CRP
levels (<italic>P</italic>=0.02), PLR (<italic>P</italic>=0.002) and NLR
(<italic>P</italic>=0.04) in the preoperative period, increased leukocyte counts
(<italic>P</italic>=0.03), CRP levels (<italic>P</italic>=0.02), NLR
(<italic>P</italic>=0.002) and PLR (<italic>P</italic>=0.01) in the first
postoperative day and prolonged intubation time (<italic>P</italic>=0.006) were
found as independent predictors of early postoperative AKI.</p><table-wrap id="t5" orientation="portrait" position="float"><label>Table 5</label><caption><p>Univariate and multivariate regression analyses of preoperative, operative
and early postoperative risk factors for postoperative AKI.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="40%" span="1"/><col width="20%" span="1"/><col width="10%" span="1"/><col width="20%" span="1"/><col width="10%" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Variables</th><th align="center" colspan="4" rowspan="1">Postoperative AKI</th></tr><tr><th align="center" rowspan="1" colspan="1">Unadjusted<break/>OR (95% CI)</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic>
</th><th align="center" rowspan="1" colspan="1">Adjusted<break/>OR (95% CI)</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Gender</td><td align="center" rowspan="1" colspan="1">0.91 (0.48-1.73)</td><td align="center" rowspan="1" colspan="1">0.87</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">__</td></tr><tr><td align="left" rowspan="1" colspan="1">Age</td><td align="center" rowspan="1" colspan="1">1.02 (0.99-1.05)</td><td align="center" rowspan="1" colspan="1">0.16</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">__</td></tr><tr><td align="left" rowspan="1" colspan="1">Ejection fraction (%)</td><td align="center" rowspan="1" colspan="1">0.98 (0.95-1.01)</td><td align="center" rowspan="1" colspan="1">0.15</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">__</td></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes mellitus</td><td align="center" rowspan="1" colspan="1">1.70 (0.97-2.98)</td><td align="center" rowspan="1" colspan="1">0.17</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">__</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension</td><td align="center" rowspan="1" colspan="1">1.25 (0.70-2.24)</td><td align="center" rowspan="1" colspan="1">0.46</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">__</td></tr><tr><td align="left" rowspan="1" colspan="1">Hyperlipidaemia</td><td align="center" rowspan="1" colspan="1">0.83 (0.47-1.45)</td><td align="center" rowspan="1" colspan="1">0.51</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">__</td></tr><tr><td align="left" rowspan="1" colspan="1">Smoking</td><td align="center" rowspan="1" colspan="1">1.47 (0.84-2.58)</td><td align="center" rowspan="1" colspan="1">0.18</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">__</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI</td><td align="center" rowspan="1" colspan="1">1.05 (0.98-1.12)</td><td align="center" rowspan="1" colspan="1">0.20</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">__</td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative creatinine (mg/dl)</td><td align="center" rowspan="1" colspan="1">2464.06 (383.62-15827.07)</td><td align="center" rowspan="1" colspan="1">0.0001</td><td align="center" rowspan="1" colspan="1">4097.94 (52.93-317299.77)</td><td align="center" rowspan="1" colspan="1">0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative urea (mg/dl)</td><td align="center" rowspan="1" colspan="1">1.12 (1.07-1.17)</td><td align="center" rowspan="1" colspan="1">0.0001</td><td align="center" rowspan="1" colspan="1">1.05 (0.94-1.18)</td><td align="center" rowspan="1" colspan="1">0.37</td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative platelet (x10<sup>3</sup>/&#x000b5;L) </td><td align="center" rowspan="1" colspan="1">1.00 (0.99-1.01)</td><td align="center" rowspan="1" colspan="1">0.12</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">__</td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative CRP (mg/l)</td><td align="center" rowspan="1" colspan="1">3.17 (2.12-4.75)</td><td align="center" rowspan="1" colspan="1">0.0001</td><td align="center" rowspan="1" colspan="1">2.71 (1.16-6.35)</td><td align="center" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative hemoglobin (mg/dl)</td><td align="center" rowspan="1" colspan="1">1.13 (0.92-1.37)</td><td align="center" rowspan="1" colspan="1">0.24</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">__</td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative leukocyte (x10<sup>3</sup>/&#x000b5;L)</td><td align="center" rowspan="1" colspan="1">0.99 (0.98-1.00)</td><td align="center" rowspan="1" colspan="1">0.44</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">__</td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative NLR</td><td align="center" rowspan="1" colspan="1">1.76 (1.38-2.23)</td><td align="center" rowspan="1" colspan="1">0.0001</td><td align="center" rowspan="1" colspan="1">0.45 (0.22-0.95)</td><td align="center" rowspan="1" colspan="1">0.04</td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative PLR</td><td align="center" rowspan="1" colspan="1">1.05 (1.03-1.07)</td><td align="center" rowspan="1" colspan="1">0.0001</td><td align="center" rowspan="1" colspan="1">1.06 (1.02-1.10)</td><td align="center" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">Postoperative first day platelet
(x10<sup>3</sup>/&#x000b5;L)&#x000a0; </td><td align="center" rowspan="1" colspan="1">1.32 (1.08-1.62)</td><td align="center" rowspan="1" colspan="1">0.007</td><td align="center" rowspan="1" colspan="1">1.00 (0.99-1.01)</td><td align="center" rowspan="1" colspan="1">0.20</td></tr><tr><td align="left" rowspan="1" colspan="1">Postoperative first day hemoglobin (mg/l)</td><td align="center" rowspan="1" colspan="1">0.90 (0.70-1.16)</td><td align="center" rowspan="1" colspan="1">0.42</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">__</td></tr><tr><td align="left" rowspan="1" colspan="1">Postoperative first day leukocyte
(x10<sup>3</sup>/&#x000b5;L)</td><td align="center" rowspan="1" colspan="1">0.97 (0.92-1.02)</td><td align="center" rowspan="1" colspan="1">0.0001</td><td align="center" rowspan="1" colspan="1">1.01(0.99-1.03)</td><td align="center" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" rowspan="1" colspan="1">Postoperative first day CRP (mg/l)</td><td align="center" rowspan="1" colspan="1">1.25 (1.17-1.33)</td><td align="center" rowspan="1" colspan="1">0.0001</td><td align="center" rowspan="1" colspan="1">1.19 (1.02-1.36)</td><td align="center" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" rowspan="1" colspan="1">Postoperative first day NLR</td><td align="center" rowspan="1" colspan="1">2.46 (1.97-3.07)</td><td align="center" rowspan="1" colspan="1">0.0001</td><td align="center" rowspan="1" colspan="1">3.04 (1.51-6.10)</td><td align="center" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">Postoperative first day PLR</td><td align="center" rowspan="1" colspan="1">1.09 (1.07-1.12)</td><td align="center" rowspan="1" colspan="1">0.0001</td><td align="center" rowspan="1" colspan="1">1.06 (1.01-1.10)</td><td align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Aortic cross clamp time</td><td align="center" rowspan="1" colspan="1">1.01 (0.99-1.03)</td><td align="center" rowspan="1" colspan="1">0.48</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">__</td></tr><tr><td align="left" rowspan="1" colspan="1">Number of distal anastomoses</td><td align="center" rowspan="1" colspan="1">1.11 (0.82-1.49)</td><td align="center" rowspan="1" colspan="1">0.50</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">__</td></tr><tr><td align="left" rowspan="1" colspan="1">CPB time</td><td align="center" rowspan="1" colspan="1">1.01 (0.99-1.03)</td><td align="center" rowspan="1" colspan="1">0.37</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">__</td></tr><tr><td align="left" rowspan="1" colspan="1">Intubation time </td><td align="center" rowspan="1" colspan="1">1.44 (1.27-1.63)</td><td align="center" rowspan="1" colspan="1">0.0001</td><td align="center" rowspan="1" colspan="1">1.64 (1.15-2.33)</td><td align="center" rowspan="1" colspan="1">0.006</td></tr><tr><td align="left" rowspan="1" colspan="1">Use of blood products</td><td align="center" rowspan="1" colspan="1">1.13 (0.65-1.97)</td><td align="center" rowspan="1" colspan="1">0.67</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">__</td></tr><tr><td align="left" rowspan="1" colspan="1">Use of inotropic support</td><td align="center" rowspan="1" colspan="1">2.28 (1.16-4.48)</td><td align="center" rowspan="1" colspan="1">0.02</td><td align="center" rowspan="1" colspan="1">0.31(0.08-2.29)</td><td align="center" rowspan="1" colspan="1">0.17</td></tr><tr><td align="left" rowspan="1" colspan="1">Amount of drainage </td><td align="center" rowspan="1" colspan="1">1.00 (0.99-1.01)</td><td align="center" rowspan="1" colspan="1">0.18</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">__</td></tr></tbody></table><table-wrap-foot><fn id="TFN10"><p>AF=atrial fibrillation; BMI = body mass index; CPB=cardiopulmonary
bypass; CRP=C-reactive protein; NLR=neutrophil to lymphocyte ratio;
PLR=platelet to lymphocyte ratio</p></fn></table-wrap-foot></table-wrap><p>The ROC curves for preoperative NLR and PLR were in connection with postoperative AKI
following isolated CABG (<xref ref-type="fig" rid="f1">Figure 1</xref>). The area
under curve (AUC) for the preoperative NLR was 0.697 (95% CI 0.620- 0.774;
<italic>P</italic>=0.0001). Using a cut-off value of 2.65, the preoperative PLR
predicted postoperative AKI with a sensitivity of 66.1% and specificity of 64.7%.
The AUC for the preoperative PLR was 0.786 (95% CI 0.719- 0.851; =0.0001). Using a
cut-off value of 136.85, the preoperative PLR predicted postoperative AKI with a
sensitivity of 71.0% and specificity of 70.7%.</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>ROC curve analysis or preoperative PLR and NLR regarding occurrence of
postoperative AKI.</p></caption><graphic xlink:href="rbccv-33-03-0233-g01"/></fig>
</p><p>The ROC curves for the postoperative first day NLR and PLR were in connection with
postoperative AKI following isolated CABG (<xref ref-type="fig" rid="f2">Figure
2</xref>). The AUC for the preoperative NLR was 0.864 (95% CI 0.815- 0.914;
<italic>P</italic>=0.0001). Using a cut-off value of 6.15, the preoperative PLR
predicted postoperative AKI with a sensitivity of 80.6% and specificity of 77.9%.
The AUC for the preoperative PLR was 0.899 (95% CI 0.856- 0.943;
<italic>P</italic>=0.0001). Using a cut-off value of 139.25, the preoperative PLR
predicted postoperative AKI with a sensitivity of 82.3% and specificity of
81.1%.</p><p>
<fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>ROC curve analysis or postoperative first day PLR and NLR regarding
occurrence of postoperative AKI.</p></caption><graphic xlink:href="rbccv-33-03-0233-g02"/></fig>
</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>In this study, increased preoperative and early postoperative NLR and PLR were
associated with postoperative AKI following isolated CABG operation. To the best of
our knowledge; this is the first study to evaluate the association of NLR and PLR
with early postoperative AKI after CABG operation.</p><p>AKI is a common postoperative complication of cardiac surgery, associated with a
prolonged hospital stay and increased morbidity and mortality, even for patients who
do not progress to renal failure. The incidence of AKI following cardiac surgery is
5-30%<sup>[</sup><sup><xref rid="r2" ref-type="bibr">2</xref></sup><sup>]</sup>.
In our study, we have identified the occurrence of AKI after CABG as 19.9%.</p><p>The pathophysiology of AKI is complex and multifactorial, and the locus of injury is
typically the tubular cells and involves toxins (exogenous and endogenous),
inflammation, ischemia-reperfusion injury, neurohormonal activation, metabolic
factors and oxidative stress<sup>[</sup><sup><xref rid="r11" ref-type="bibr">11</xref></sup><sup>]</sup>. Another cause of AKI following cardiac surgery
could be a pro-inflammatory event such as operative trauma, blood exposed to the
artificial surface of the CPB circuit or ischaemia-reperfusion
injury<sup>[</sup><sup><xref rid="r2" ref-type="bibr">2</xref></sup><sup>]</sup>. C-reactive protein is a marker of inflammation that
is extensively used in clinical practice. Recently, several prospective clinical
studies have shown that modest elevations in baseline CRP levels predict future
cardiovascular events<sup>[</sup><sup><xref rid="r12" ref-type="bibr">12</xref></sup><sup>]</sup>. Shacham et al.<sup>[</sup><sup><xref rid="r13" ref-type="bibr">13</xref></sup><sup>]</sup> reported &#x0003e;9 mg/l of
high sensitive CRP levels as an independent risk factor for AKI following primary
percutanous interventions of the patients with ST-elevated myocardial infarction
(STEMI). In our study, we found that the preoperative and early postoperative
increased CRP levels are independent risk factors for the development of AKI in the
early postoperative period.</p><p>Several inflammatory biomarkers including white blood cell (WBC) count, leukocyte
subtypes, platelet, CRP, NLR and PLR have been demonstrated to be important
prognostic predictors in various cardiovascular diseases<sup>[</sup><sup><xref rid="r14" ref-type="bibr">14</xref></sup><sup>]</sup>. Each WBC subtype,
including neutrophils, lymphocytes, monocytes, and eosinophils, has a discrete role
in inflammation, host defense, and repair<sup>[</sup><sup><xref rid="r15" ref-type="bibr">15</xref></sup><sup>]</sup>. Each of these components are one of
the immunologic factors that play a pivotal role in most processes of organ damage
and this role can apply to the issue of kidney damage<sup>[</sup><sup><xref rid="r16" ref-type="bibr">16</xref></sup><sup>]</sup>. In our study, we have
determined that the blood leukocyte levels were significantly higher in the AKI
group in the 1<sup>st</sup> and 3<sup>rd</sup> days postoperatively.</p><p>NLR is a new inflammatory marker which is associated with
inflammation<sup>[</sup><sup><xref rid="r17" ref-type="bibr">17</xref></sup><sup>]</sup>. It has also been shown that NLR was associated
with adverse events following CABG in stable and unstable angina pectoris.
&#x000dc;nal et al.<sup>[</sup><sup><xref rid="r18" ref-type="bibr">18</xref></sup><sup>]</sup> have observed that preoperative NLR was correlated
with mortality after CABG. Yilmaz et al.<sup>[</sup><sup><xref rid="r19" ref-type="bibr">19</xref></sup><sup>]</sup> reported that NLR is superior to CRP
and WBC, to predict the development of AKI in the patients with severe sepsis. In
our study, we identified that the preoperative and postoperative NLR values were
significantly high in patients with AKI.</p><p>To our knowledge, there have been no studies in the literature with patients who
underwent isolated CABG with CPB, that investigated the relationship between the
development of postoperative AKI and NLR as a biomarker, so we suppose that our
findings are valuable. PLR is a recently defined hematological parameter which is
associated with both aggregation and inflammation pathways, and it can be more
valuable than either platelet or lymphocyte counts alone in predicting coronary
artery disease<sup>[</sup><sup><xref rid="r20" ref-type="bibr">20</xref></sup><sup>]</sup>. PLR has been used to predict the prognosis of
patients with different inflammatory and ischemic events in the
literature<sup>[</sup><sup><xref rid="r21" ref-type="bibr">21</xref></sup><sup>]</sup>. Temiz et al.<sup>[</sup><sup><xref rid="r22" ref-type="bibr">22</xref></sup><sup>]</sup> have observed elevated PLR to be
associated with hospital mortality in patients with STEMI. Akin et
al.<sup>[</sup><sup><xref rid="r23" ref-type="bibr">23</xref></sup><sup>]</sup> reported in their study including 630 patients who
underwent percutanous coronary intervention (PCI) after STEMI that the patients who
had higher PLR values before the procedure developed contrast-induced AKI. In our
study PLR values of AKI Group were significantly high.</p><sec><title>Limitations of the Study</title><p>A few limitations of our study deserve mention. This is a single centre
retrospective study with a relatively small sample size. Although we have found
some parameters associated with AKI, we could not draw a causal
relationship.</p></sec></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>In our study, we observed that elevated NLR and PLR were independent predictors of
early postoperative AKI following isolated CABG. NLR and PLR, which can easily be
obtained from a simple whole blood count, may predict adverse events after CABG.
Although we could not establish a causal relationship in this study, the results of
this study may have some clinical implications if approved by large scale
prospective studies.</p><table-wrap id="t7" orientation="portrait" position="float"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="95%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">HP</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; final approval of the version
to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">H&#x0015e;</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; final approval of the version
to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at Department of Cardiovascular Surgery, Derince
Training and Research Hospital, Kocaeli, Turkey.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><fn-group><fn fn-type="financial-disclosure"><p>No financial support.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ricci</surname><given-names>Z</given-names></name><name><surname>Di Nardo</surname><given-names>M</given-names></name><name><surname>Iacoella</surname><given-names>C</given-names></name><name><surname>Netto</surname><given-names>R</given-names></name><name><surname>Picca</surname><given-names>S</given-names></name><name><surname>Cogo</surname><given-names>P</given-names></name></person-group><article-title>Pediatric RIFLE for acute kidney injury diagnosis and prognosis
for children undergoing cardiac surgery: a single-center prospective
observational study</article-title><source>Pediatr Cardiol</source><year>2013</year><volume>34</volume><issue>6</issue><fpage>1404</fpage><lpage>1408</lpage><pub-id pub-id-type="pmid">23430323</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takaki</surname><given-names>S</given-names></name><name><surname>Shehabi</surname><given-names>Y</given-names></name><name><surname>Pickering</surname><given-names>JW</given-names></name><name><surname>Endre</surname><given-names>Z</given-names></name><name><surname>Miyashita</surname><given-names>T</given-names></name><name><surname>Goto</surname><given-names>T</given-names></name></person-group><article-title>Perioperative change in creatinine following cardiac surgery with
cardiopulmonary bypass is useful in predicting acute kidney injury: a
single-centre retrospective cohort study</article-title><source>Interact Cardiovasc Thorac Surg</source><year>2015</year><volume>21</volume><issue>4</issue><fpage>465</fpage><lpage>469</lpage><pub-id pub-id-type="pmid">26160965</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freeland</surname><given-names>K</given-names></name><name><surname>Hamidian Jahromi</surname><given-names>A</given-names></name><name><surname>Duvall</surname><given-names>LM</given-names></name><name><surname>Mancini</surname><given-names>MC</given-names></name></person-group><article-title>Postoperative blood transfusion is an independent predictor of
acute kidney injury in cardiac surgery patients</article-title><source>J Nephropathol</source><year>2015</year><volume>4</volume><issue>4</issue><fpage>121</fpage><lpage>126</lpage><pub-id pub-id-type="pmid">26457259</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigues</surname><given-names>AJ</given-names></name><name><surname>Evora</surname><given-names>PRB</given-names></name><name><surname>Bassetto</surname><given-names>S</given-names></name><name><surname>Alves J&#x000fa;nior</surname><given-names>L</given-names></name><name><surname>Scorzoni Filho</surname><given-names>A</given-names></name><name><surname>Ara&#x000fa;jo</surname><given-names>WF</given-names></name><etal/></person-group><article-title>Risk factors for acute kidney injury after cardiac
surgery</article-title><source>Rev Bras Cir Cardiovasc</source><year>2009</year><volume>24</volume><issue>4</issue><fpage>441</fpage><lpage>446</lpage><pub-id pub-id-type="pmid">20305915</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brito</surname><given-names>DJA</given-names></name><name><surname>Nina</surname><given-names>VJS</given-names></name><name><surname>Nina</surname><given-names>RVAH</given-names></name><name><surname>Figueiredo Neto</surname><given-names>JA</given-names></name><name><surname>Oliveira</surname><given-names>MIG</given-names></name><name><surname>Salgado</surname><given-names>JVL</given-names></name><etal/></person-group><article-title>Prevalence and risk factors for acute renal failure in the
postoperative of coronary artery bypass grafting</article-title><source>Rev Bras Cir Cardiovasc</source><year>2009</year><volume>24</volume><issue>3</issue><fpage>297</fpage><lpage>304</lpage><pub-id pub-id-type="pmid">20011874</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhat</surname><given-names>T</given-names></name><name><surname>Teli</surname><given-names>S</given-names></name><name><surname>Rijal</surname><given-names>J</given-names></name><name><surname>Bhat</surname><given-names>H</given-names></name><name><surname>Raza</surname><given-names>M</given-names></name><name><surname>Khoueiry</surname><given-names>G</given-names></name><etal/></person-group><article-title>Neutrophil to lymphocyte ratio and cardiovascular diseases: a
review</article-title><source>Expert Rev Cardiovasc Ther</source><year>2013</year><volume>11</volume><issue>1</issue><fpage>55</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">23259445</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Proctor</surname><given-names>MJ</given-names></name><name><surname>McMillan</surname><given-names>DC</given-names></name><name><surname>Morrison</surname><given-names>DS</given-names></name><name><surname>Fletcher</surname><given-names>CD</given-names></name><name><surname>Horgan</surname><given-names>PG</given-names></name><name><surname>Clarke</surname><given-names>SJ</given-names></name></person-group><article-title>A derived neutrophil to lymphocyte ratio predicts survival in
patients with cancer</article-title><source>Br J Cancer</source><year>2012</year><volume>107</volume><issue>4</issue><fpage>695</fpage><lpage>699</lpage><pub-id pub-id-type="pmid">22828611</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Yang</surname><given-names>JX</given-names></name><name><surname>Cao</surname><given-names>DY</given-names></name><name><surname>Wan</surname><given-names>XR</given-names></name><name><surname>Feng</surname><given-names>FZ</given-names></name><name><surname>Huang</surname><given-names>HF</given-names></name><etal/></person-group><article-title>Preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios
as independent predictors of cervical stromal involvement in surgically
treated endometrioid adenocarcinoma</article-title><source>Onco Targets Ther</source><year>2013</year><volume>6</volume><fpage>211</fpage><lpage>216</lpage><pub-id pub-id-type="pmid">23525143</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okusa</surname><given-names>MD</given-names></name><name><surname>Davenport</surname><given-names>A</given-names></name></person-group><article-title>Reading between the (guide)lines: the KDIGO practice guideline on
acute kidney injury in the individual patient</article-title><source>Kidney Int</source><year>2014</year><volume>85</volume><issue>1</issue><fpage>39</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">24067436</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JY</given-names></name><name><surname>Joung</surname><given-names>KW</given-names></name><name><surname>Kim</surname><given-names>KM</given-names></name><name><surname>Kim</surname><given-names>MJ</given-names></name><name><surname>Kim</surname><given-names>JB</given-names></name><name><surname>Jung</surname><given-names>SH</given-names></name><etal/></person-group><article-title>Relationship between a perioperative intravenous fluid
administration strategy and acute kidney injury following off-pump coronary
artery bypass surgery: an observational study</article-title><source>Crit Care</source><year>2015</year><volume>19</volume><fpage>350</fpage><lpage>350</lpage><pub-id pub-id-type="pmid">26415535</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kramer</surname><given-names>RS</given-names></name><name><surname>Herron</surname><given-names>CR</given-names></name><name><surname>Groom</surname><given-names>RC</given-names></name><name><surname>Brown</surname><given-names>JR</given-names></name></person-group><article-title>Acute kidney injury subsequent to cardiac surgery</article-title><source>J Extra Corpor Technol</source><year>2015</year><volume>47</volume><issue>1</issue><fpage>16</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">26390675</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thiele</surname><given-names>JR</given-names></name><name><surname>Zeller</surname><given-names>J</given-names></name><name><surname>Bannasch</surname><given-names>H</given-names></name><name><surname>Stark</surname><given-names>GB</given-names></name><name><surname>Peter</surname><given-names>K</given-names></name><name><surname>Eisenhardt</surname><given-names>SU</given-names></name></person-group><article-title>Targeting C-reactive protein in inflammatory disease by
preventing conformational changes</article-title><source>Mediators Inflamm</source><year>2015</year><volume>2015</volume><elocation-id>372432</elocation-id><pub-id pub-id-type="pmid">26089599</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shacham</surname><given-names>Y</given-names></name><name><surname>Leshem-Rubinow</surname><given-names>E</given-names></name><name><surname>Steinvil</surname><given-names>A</given-names></name><name><surname>Keren</surname><given-names>G</given-names></name><name><surname>Roth</surname><given-names>A</given-names></name><name><surname>Arbel</surname><given-names>Y</given-names></name></person-group><article-title>High sensitive C-reactive protein and the risk of acute kidney
injury among ST elevation myocardial infarction patients undergoing primary
percutaneous intervention</article-title><source>Clin Exp Nephrol</source><year>2015</year><volume>19</volume><issue>5</issue><fpage>838</fpage><lpage>843</lpage><pub-id pub-id-type="pmid">25492251</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oylumlu</surname><given-names>M</given-names></name><name><surname>Y&#x00131;ld&#x00131;z</surname><given-names>A</given-names></name><name><surname>Oylumlu</surname><given-names>M</given-names></name><name><surname>Y&#x000fc;ksel</surname><given-names>M</given-names></name><name><surname>Polat</surname><given-names>N</given-names></name><name><surname>Bilik</surname><given-names>MZ</given-names></name><etal/></person-group><article-title>Platelet-to-lymphocyte ratio is a predictor of in-hospital
mortality patients with acute coronary syndrome</article-title><source>Anatol J Cardiol</source><year>2015</year><volume>5</volume><issue>4</issue><fpage>277</fpage><lpage>283</lpage></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>SS</given-names></name><name><surname>Ahn</surname><given-names>SY</given-names></name><name><surname>Ryu</surname><given-names>J</given-names></name><name><surname>Baek</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>KI</given-names></name><name><surname>Chin</surname><given-names>HJ</given-names></name><etal/></person-group><article-title>U-shape relationship of white blood cells with acute kidney
injury and mortality in critically ill patients</article-title><source>Tohoku J Exp Med</source><year>2014</year><volume>232</volume><issue>3</issue><fpage>177</fpage><lpage>185</lpage><pub-id pub-id-type="pmid">24621861</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Babio</surname><given-names>N</given-names></name><name><surname>Ibarrola-Jurado</surname><given-names>N</given-names></name><name><surname>Bull&#x000f3;</surname><given-names>M</given-names></name><name><surname>Mart&#x000ed;nez-Gonz&#x000e1;lez</surname><given-names>M&#x000c1;</given-names></name><name><surname>W&#x000e4;rnberg</surname><given-names>J</given-names></name><name><surname>Salaverr&#x000ed;a</surname><given-names>I</given-names></name><etal/><collab>PREDIMED Study Investigators</collab></person-group><article-title>White blood cell counts as risk markers of developing metabolic
syndrome and its components in the PREDIMED study</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><issue>3</issue><elocation-id>e58354</elocation-id><pub-id pub-id-type="pmid">23526980</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibson</surname><given-names>PH</given-names></name><name><surname>Cuthbertson</surname><given-names>BH</given-names></name><name><surname>Croal</surname><given-names>BL</given-names></name><name><surname>Rae</surname><given-names>D</given-names></name><name><surname>El-Shafei</surname><given-names>H</given-names></name><name><surname>Gibson</surname><given-names>G</given-names></name><etal/></person-group><article-title>Usefulness of neutrophil/lymphocyte ratio as predictor of
new-onset atrial fibrillation after coronary artery bypass
grafting</article-title><source>Am J Cardiol</source><year>2010</year><volume>105</volume><issue>2</issue><fpage>186</fpage><lpage>191</lpage><pub-id pub-id-type="pmid">20102916</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x000dc;nal</surname><given-names>EU</given-names></name><name><surname>Durukan</surname><given-names>AB</given-names></name><name><surname>&#x000d6;zen</surname><given-names>A</given-names></name><name><surname>Kubat</surname><given-names>E</given-names></name><name><surname>Kocabeyoglu</surname><given-names>SS</given-names></name><name><surname>Yurdakok</surname><given-names>O</given-names></name><etal/></person-group><article-title>Neutrophil/lymphocyte ratio as a mortality predictor following
coronary artery bypass graft surgery</article-title><source>Turk Gogus Kalp Dama</source><year>2013</year><volume>21</volume><issue>3</issue><fpage>588</fpage><lpage>593</lpage></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yilmaz</surname><given-names>H</given-names></name><name><surname>Cakmak</surname><given-names>M</given-names></name><name><surname>Inan</surname><given-names>O</given-names></name><name><surname>Darcin</surname><given-names>T</given-names></name><name><surname>Akcay</surname><given-names>A</given-names></name></person-group><article-title>Can neutrophil-lymphocyte ratio be independent risk factor for
predicting acute kidney injury in patients with severe
sepsis?</article-title><source>Ren Fail</source><year>2015</year><volume>37</volume><issue>2</issue><fpage>225</fpage><lpage>229</lpage><pub-id pub-id-type="pmid">25394529</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azab</surname><given-names>B</given-names></name><name><surname>Shah</surname><given-names>N</given-names></name><name><surname>Akerman</surname><given-names>M</given-names></name><name><surname>McGinn Jr</surname><given-names>JT</given-names></name></person-group><article-title>Value of platelet/lymphocyte ratio as a predictor of all-cause
mortality after non-ST-elevation myocardial infarction</article-title><source>J Thromb Thrombolysis</source><year>2012</year><volume>34</volume><issue>3</issue><fpage>326</fpage><lpage>334</lpage><pub-id pub-id-type="pmid">22466812</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turkmen</surname><given-names>K</given-names></name><name><surname>Erdur</surname><given-names>FM</given-names></name><name><surname>Ozcicek</surname><given-names>F</given-names></name><name><surname>Ozcicek</surname><given-names>A</given-names></name><name><surname>Akbas</surname><given-names>EM</given-names></name><name><surname>Ozbicer</surname><given-names>A</given-names></name><etal/></person-group><article-title>Platelet-to-lymphocyte ratio better predicts inflammation than
neutrophil-to-lymphocyte ratio in end-stage renal disease
patients</article-title><source>Hemodial Int</source><year>2013</year><volume>17</volume><issue>3</issue><fpage>391</fpage><lpage>396</lpage><pub-id pub-id-type="pmid">23522328</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Temiz</surname><given-names>A</given-names></name><name><surname>Gazi</surname><given-names>E</given-names></name><name><surname>G&#x000fc;ng&#x000f6;r</surname><given-names>&#x000d6;</given-names></name><name><surname>Barut&#x000e7;u</surname><given-names>A</given-names></name><name><surname>Altun</surname><given-names>B</given-names></name><name><surname>Bekler</surname><given-names>A</given-names></name><etal/></person-group><article-title>Platelet/lymphocyte ratio and risk of in-hospital mortality in
patients with ST-elevated myocardial infarction</article-title><source>Med Sci Monit</source><year>2014</year><volume>20</volume><fpage>660</fpage><lpage>665</lpage><pub-id pub-id-type="pmid">24751474</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akin</surname><given-names>F</given-names></name><name><surname>Celik</surname><given-names>O</given-names></name><name><surname>Altun</surname><given-names>I</given-names></name><name><surname>Ayca</surname><given-names>B</given-names></name><name><surname>Ozturk</surname><given-names>D</given-names></name><name><surname>Satilmis</surname><given-names>S</given-names></name><etal/></person-group><article-title>Relation of red cell distribution width to contrast-induced acute
kidney injury in patients undergoing a primary percutaneous coronary
intervention</article-title><source>Coron Artery Dis</source><year>2015</year><volume>26</volume><issue>4</issue><fpage>289</fpage><lpage>295</lpage><pub-id pub-id-type="pmid">25714066</pub-id></element-citation></ref></ref-list></back></article>